Raymond James Has Optimistic Outlook of TSE:MDP Q1 Earnings
Medexus Pharmaceuticals Inc. (TSE:MDP – Free Report) – Investment analysts at Raymond James raised their Q1 2026 EPS estimates for shares of Medexus Pharmaceuticals in a research report issued to clients and investors on Monday, March 17th. Raymond James analyst M. Freeman now forecasts that the company will earn ($0.20) per share for the quarter, […]
